Biotech News
Related news
IRIXIRIDEX2026-08-18 20:05 EST
Iridex Reports Second Quarter 2026 Financial Results
IRIXIRIDEX2026-08-04 20:05 EST
Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026
PLSEPulse Biosciences2026-09-15 11:00 EST
Pulse Biosciences Completes Enrollment in the PRECISE-BTN Clinical Study Evaluating the nPulse™ Vybrance™ Percutaneous Electrode System for Symptomatic Benign Thyroid Nodules
EYPTEyePoint Pharmaceuticals2026-07-30 11:00 EST
EyePoint Completes Enrollment of Both Pivotal Phase 3 Trials of DURAVYU™ for Treatment of Diabetic Macular Edema (DME)
IRIDEX
Ophthalmic Laser Technology Company Iridex develops, manufactures, and markets laser-based medical systems, delivery devices, and accessories for ophthalmology. Its products are used by eye-care specialists to treat glaucoma, diabetic macular edema, and other retinal diseases. MicroPulse Technology The company's proprietary MicroPulse...
Recent company news
IRIXIRIDEX2026-10-05 11:00 EST
Iridex Completes Relocation of Manufacturing Facility to San Jose, California
IRIXIRIDEX2026-08-18 20:05 EST
Iridex Reports Second Quarter 2026 Financial Results
IRIXIRIDEX2026-08-04 20:05 EST
Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026
IRIXIRIDEX2026-07-20 11:00 EST
Iridex Adds EndoProbe® Handpieces to EyeProGPO Product Offering
IRIXIRIDEX2026-06-09 20:05 EST
Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference
Stock data
- Close
- 0.63 USD
- Market cap
- 20.37M USD
- Exchange
- NASDAQ
- Sector
- Biopharma
- Location
- United States